Journal List > Lab Med Online > v.9(3) > 1131947

Park, Kim, Chang, Kim, Yoo, Kim, Sung, and Kim: A Case of Chronic Strongyloidiasis with Recurrent Hyperinfection

Abstract

Strongyloides stercoralis is an intestinal nematode that often causes chronic diarrhea and may develop severe complicated form of hyperinfection or disseminated infection in immunocompromised patients. Here, we report a case of recurrent strongyloidiasis presenting with pulmonary and meningeal involvement. A 55-year-old male diagnosed with pancreatic cancer 4 months ago was admitted due to chronic diarrhea, abdominal pain, and weight loss for 2–3 months. He had been treated with albendazole for chronic recurrent strongyloidiasis 13 years ago and again 2 years ago. He developed sepsis of Klebsiella pneumoniae and Escherichia coli on Days 3 and 7, respectively, and then meningitis of E. coli on Day 42. Strongyloidiasis was diagnosed by detection of abundant filariform larvae in sputum specimens on Day 15. He was treated for disseminated strongyloidiasis with albendazole and ivermectin for five weeks until clearance of larvae was confirmed in sputum and stool specimens. Laboratory diagnosis is important to guide appropriate treatment and to prevent chronic and recurrent strongyloidiasis.

References

1. Sheorey H. Biggs B. Ryan N. Nematodes. Jorgensen JH, editor. editors.Manual of clinical microbiology. 11th ed.Washington, DC: ASM Press;2015. p. 2456–8.
2. Kassalik M and Mönkemüller K. Strongyloides stercoralis hyperinfection syndrome and disseminated disease. Gastroenterol Hepatol (N Y). 2011; 7:766–8.
3. Pradhan G, Behera P, Panigrahi MK, Bhuniya S, Mohapatra PR, Turuk J, et al. Pulmonary strongyloidiasis masquerading as exacerbation of chronic obstructive pulmonary disease. Tuberc Respir Dis (Seoul). 2016; 79:307–11.
crossref
4. Siddiqui AA and Berk SL. Diagnosis of Strongyloides stercoralis Infection. Clin Infect Dis. 2001; 33:1040–7.
5. Keiser PB and Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004; 17:208–17.
6. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007; 41:1992–2001.
crossref
7. Yoon DH, Yang SJ, Kim JS, Hong ST, Chai JY, Lee SH, et al. A case of fatal malabsorption syndrome caused by strongyloidiasis complicated with isosporiasis and human cytomegalovirus infection. Korean J Parasitol. 1992; 30:53–8.
crossref
8. Hong YH, Kim JW, Rheem IS, Kim JS, Kim SB, Chai JY, et al. Observation of the free-living adults of Strongyloides stercoralis from a human stool in Korea. Infect Chemother. 2009; 41:105–8.
crossref
9. Kim YJ, Ahn MJ, Park KC, Lee HY, Kim KH, Byeon KM, et al. Pulmonary strongyloidiasis with alveolar hemorrhage in a patient receiving chemotherapy. Korean J Med. 2009; 76:502–5.
10. Kim J, Joo HS, Kim DH, Lim H, Kang YH, Kim MS. A case of gastric strongyloidiasis in a Korean patient. Korean J Parasitol. 2003; 41:63–7.
crossref
11. Schar F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013; 7:e2288.
crossref
12. Cho SH, Jung BS, Lee SE. National survey of intestinal parasitic infections in Korea, 8th Report. 2013. https://www.cdc.go.kr/CDC/info/Cdc-KrInfo0301.jsp?menuIds=HOME006-MNU3003-MNU2950-MNU2951&cid=24152. [Updated on Jan 2014].
13. Lee SK, Shin BM, Chung NS, Chai JY, Lee SH. Second report on intestinal parasites among the patients of Seoul Paik Hospital (1984–1992). Korean J Parasitol. 1994; 32:27–33.
crossref
14. Chai JY, Park JH, Guk SM, Kim HJ, Kim WH, Kim JL, et al. Status of intestinal parasite infections among 4,137 residents from provinces nationwide and metropolitan areas in the Republic of Korea (2004). Infect Chemother. 2006; 38:198–203.
15. Kim HS, Kim YE, Yun EY, Ju JH, Ma JE, Lee GD, et al. A case of fatal hyperinfective strongyloidiasis with acute respiratory failure and intestinal perforation in lung cancer patient. Tuberc Respir Dis (Seoul). 2010; 68:29–33.
crossref
16. Cho JY, Kwon JG, Ha KH, Oh JY, Jin MI, Heo SW, et al. A case of steroid-induced hyperinfective strongyloidiasis with bacterial meningitis. Korean J Gastroenterol. 2012; 60:330–4.
crossref
17. Rah YM, Yun SA, Yoon HJ, Lee SY. Strongyloides hyperinfection in an elderly patient treated for stomach cancer. J Korean Geriatr Soc. 2014; 18:41–5.
18. Mejia R and Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis. 2012; 25:458–63.
19. Gill GV and Bell DR. Strongyloides stercoralis infection in former far east prisoners of war. Br Med J. 1979; 2:572.
20. Buonfrate D, Requena-Mendez A, Angheben A, Munoz J, Gobbi F, Van Den Ende J, et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis. 2013; 13:78.
crossref

Fig. 1.
Microscopy of sputum and stool specimens showing Strongyloides stercoralis larvae. (A) coiled larvae (arrowheads) of spiral shape in endotracheal aspirates (gram stain, ×100) (B) filariform stage which has long esophagus, and notched tail end in endotracheal aspirates (formalin-fixed, ×400) (C) rhabditiform stage which has short buccal cavity in stool (formalin-fixed, ×400).
lmo-9-171f1.tif
Fig. 2.
Clinical and laboratory findings of the present case, including bowel habit, antihelminth treatment, parasitic examination of sputum and stool specimens, leukocyte count of peripheral blood, and bacterial cultures of blood and cerebrospinal fluid. D, denoted diarrhea; 0, Not observed; 1, 1–2/cover glass; 2, 3–9/cover glass; 3, ≥10/cover glass as a quantitation of larvae per 22 mm cover glass of wet mount in sputum and stool specimens; , No growth from blood culture; , Klebsiella pneumoniae from blood culture; , Escherichia coli from blood culture; , Escherichia coli from cerebrospinal fluid culture.
lmo-9-171f2.tif
Table 1.
Case presentation of hyperinfective strongyloidiasis in Korea, 2010–2018
No. Age/ sex Year of report Underlying disease Immunosuppression Primary sample identified Bacteremia Meningitis Therapy Prognosis
1 65/M 2010 [15] Lung cancer Corticosteroid Sputum + (Enterobacter cloacae) Albendazole 800 mg/day, 6 days Improved
2 73/F 2012 [16] Heart Disease Corticosteroid Bronchoalveolar lavage + (Enterococcus faecium) Present Albendazole 400 mg/day, 6 days Deceased
3 71/M 2014 [17] Gastric Cancer No Gastric tissue Ivermectin 15 mg/day, 2 days Improved
4 55/M Present case Pancreatic cancer No Bronchoalveolar lavage + (Escherichia coli, Klebsiella pneumoniae) Present Albendazole 400 mg/day+ Ivermectin 12 mg/day, ≥4 weeks Not improved
TOOLS
Similar articles